Literature DB >> 3462746

Structure and gene organization of bovine neuromedin K precursor.

H Kotani, M Hoshimaru, H Nawa, S Nakanishi.   

Abstract

cDNA and genomic DNA clones for the precursor of a mammalian neuropeptide tachykinin, neuromedin K, have been isolated and characterized by molecular cloning and sequence analysis. The deduced amino acid sequence indicates that the bovine neuromedin K precursor (preprotachykinin B) consists of 126 amino acid residues including a putative signal peptide. There are two preprotachykinin B mRNAs that differ only at the 5' extremity of the untranslated regions. The major mRNA species is encoded by seven exon sequences, while the minor species includes two extra 5' exon sequences and lacks the 5' terminus of the first exon sequence for the major mRNA species. The above gene organization for the major preprotachykinin B mRNA closely resembles that for the preprotachykinin A mRNA encoding the precursor for substance P and substance K. This structural resemblance strongly suggests that the two preprotachykinin genes have evolved from a common ancestor gene. Furthermore, we have found that the preprotachykinin A and B mRNAs markedly differ in their major expression sites. The results described thus indicate that the diversity of the mammalian tachykinin system has been acquired through various cellular mechanisms including gene duplication and differential expression of duplicated genes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3462746      PMCID: PMC386655          DOI: 10.1073/pnas.83.18.7074

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

1.  Substance P and excitatory transmitter of primary sensory neurons.

Authors:  M Otsuka; S Konishi
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1976

2.  Sequence at the 3' end of globin mRNA shows homology with immunoglobulin light chain mRNA.

Authors:  N J Proudfoot; G G Brownlee
Journal:  Nature       Date:  1974-11-29       Impact factor: 49.962

3.  Nucleotide sequences of cloned cDNAs for two types of bovine brain substance P precursor.

Authors:  H Nawa; T Hirose; H Takashima; S Inayama; S Nakanishi
Journal:  Nature       Date:  1983 Nov 3-9       Impact factor: 49.962

4.  New M13 vectors for cloning.

Authors:  J Messing
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

Review 5.  Organization and expression of eucaryotic split genes coding for proteins.

Authors:  R Breathnach; P Chambon
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

6.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

Review 7.  Processing mechanisms in the biosynthesis of proteins.

Authors:  D F Steiner; P S Quinn; S J Chan; J Marsh; H S Tager
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

8.  Neuromedin K: a novel mammalian tachykinin identified in porcine spinal cord.

Authors:  K Kangawa; N Minamino; A Fukuda; H Matsuo
Journal:  Biochem Biophys Res Commun       Date:  1983-07-29       Impact factor: 3.575

9.  Pharmacological characterization of novel mammalian tachykinins, neurokinin alpha and neurokinin beta.

Authors:  S Kimura; K Goto; T Ogawa; Y Sugita; I Kanazawa
Journal:  Neurosci Res       Date:  1984-12       Impact factor: 3.304

10.  Solid phase synthesis of polynucleotides. VI. Further studies on polystyrene copolymers for the solid support.

Authors:  H Ito; Y Ike; S Ikuta; K Itakura
Journal:  Nucleic Acids Res       Date:  1982-03-11       Impact factor: 16.971

View more
  23 in total

1.  Characterization of the endokinins: human tachykinins with cardiovascular activity.

Authors:  Nigel M Page; Nicola J Bell; Sheila M Gardiner; Isaac T Manyonda; Kerensa J Brayley; Philip G Strange; Philip J Lowry
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-25       Impact factor: 11.205

Review 2.  Tachykinins and excitotoxicity in cerebellar granule cells.

Authors:  Cinzia Severini; Cristina Zona
Journal:  Cerebellum       Date:  2006       Impact factor: 3.847

Review 3.  Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease.

Authors:  Martin S Steinhoff; Bengt von Mentzer; Pierangelo Geppetti; Charalabos Pothoulakis; Nigel W Bunnett
Journal:  Physiol Rev       Date:  2014-01       Impact factor: 37.312

Review 4.  Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential.

Authors:  Inga Herpfer; Klaus Lieb
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

5.  Development of substance P and neurokinin A immunoreactivity in ganglia supplying nerves to the submandibular glands of the rat.

Authors:  E Virta; H Uusitalo
Journal:  Histochemistry       Date:  1993-10

6.  Role of neurokinin-1 receptor in the initiation and maintenance of skin chronic inflammatory diseases.

Authors:  Sherrie J Divito; Adrian E Morelli; Adriana T Larregina
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

7.  Bronchoconstrictor and hypotensive effects in relation to pharmacokinetics of tachykinins in the guinea-pig--evidence for extraneuronal cleavage of neuropeptide K to neurokinin A.

Authors:  C R Martling; E Theodorsson-Norheim; I Norheim; J M Lundberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-08       Impact factor: 3.000

8.  Substance P, neurokinin A and neurokinin B in the ocular response to injury in the rabbit.

Authors:  B Beding-Barnekow; E Brodin; R Håkanson
Journal:  Br J Pharmacol       Date:  1988-09       Impact factor: 8.739

Review 9.  Synaptic control of motoneuronal excitability.

Authors:  J C Rekling; G D Funk; D A Bayliss; X W Dong; J L Feldman
Journal:  Physiol Rev       Date:  2000-04       Impact factor: 37.312

10.  gamma-Preprotachykinin-(72-92)-peptide amide: an endogenous preprotachykinin I gene-derived peptide that preferentially binds to neurokinin-2 receptors.

Authors:  T V Dam; Y Takeda; J E Krause; E Escher; R Quirion
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.